| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 122 | 62 | 1,015 | | Cost of Revenue | 95 | 72 | 1,320 | | | Gross Profit | 28 | (10) | (306) | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,025 | 1,334 | 4,045 | | Non Recurring | 125 |
-
|
-
| | Others | 58 | 2,152 | 503 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,182) | (3,497) | (4,853) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3 | 315 | (6,125) | | Earnings Before Interest And Taxes | (2,179) | (3,182) | (10,978) | | Interest Expense | 3 | 70 | 457 | | Income Before Tax | (2,182) | (3,252) | (11,435) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,182) | (3,252) | (11,435) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,182) | (3,252) | (11,435) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,182) | ($3,252) | ($11,435) |
|
0.67% Nasdaq 
0.02 (6.67%) 
Income Statement
